1. Home
  2. TRVG vs BNTC Comparison

TRVG vs BNTC Comparison

Compare TRVG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$4.66

Market Cap

422.6M

Sector

Technology

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$8.82

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
BNTC
Founded
2005
1995
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.6M
396.3M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
TRVG
BNTC
Price
$4.66
$8.82
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$6.02
★ $24.33
AVG Volume (30 Days)
★ 175.3K
138.5K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.24
N/A
Revenue Next Year
$9.60
N/A
P/E Ratio
$16.98
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$9.26
52 Week High
$6.80
$16.76

Technical Indicators

Market Signals
Indicator
TRVG
BNTC
Relative Strength Index (RSI) 35.39 26.62
Support Level $2.75 N/A
Resistance Level $4.79 $13.49
Average True Range (ATR) 0.52 0.78
MACD -0.15 -0.15
Stochastic Oscillator 0.00 5.05

Price Performance

Historical Comparison
TRVG
BNTC

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: